Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FT084
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $86,889
Award facts
- Contract value 100% obligated
- $86,889.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $86,889.06 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL units). The contract is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and was awarded on October 20, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. As a child contract, this delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's portfolio encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Dupixent, a biologic medication used in the treatment of eczema, asthma, and other allergic conditions, exemplifies the company's role in supplying specialized pharmaceutical products to support Defense Health Agency and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FT084?
SPE2DR26FT084 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FT084 worth?
The government has obligated $86,889 on SPE2DR26FT084.
Is contract SPE2DR26FT084 an order under another contract?
Yes. SPE2DR26FT084 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT084 competed?
The extent of competition for SPE2DR26FT084 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award